Global Fully-Automatic External Defibrillators Market Overview:
Early defibrillation in combination with CPR can improve survival rates up to 74% if defibrillation occurs within three minutes of collapse. For every minute between sudden cardiac arrest and defibrillation, the chance of survival decreases to 10%. Because of this, choosing an automated external defibrillator (AED) that can be trusted to reduce unnecessary shock delays can mean the difference between life and death. All AEDs automatically analyzes the heart rhythm to determine if a shock is needed. A fully automated AED will automatically deliver a shock when needed, without the rescuer having to press a button to deliver the shock. The device transmits step-by-step instructions telling rescue workers when to shock a victim. Fully automated models are designed to help responders who may hesitate in an emergency with cardiac arrest. Studies have shown that fully automated AEDs are safe, effective, and can reduce lengthy delays associated with the hesitation to press the shock button during a rescue. Fully automated AEDs place the rescuer in a more passive and safer position during analysis and shock delivery, preventing the rescuer from taking inappropriate action. Fully automated AEDs are safe, effective, and can reduce lengthy delays associated with the hesitation to press the shock button.
- Growing Advancements in AED Technology
- Surging Geriatric Population
- Rising Popularity of Fully Automated External Defibrillator (AED)
- Increase in Severe Physical Stress Due To Heavy Mental Work Load, Smoking and Physical Inactivity
- Growing Cases of Cardiac Diseases
- Growing Trend of Using High Amplitude Current Impulse to Restore Normal Heart Function
- Increasing Investments by Private Players
- The Rising Awareness and Training Programs on Defibrillation
- High Costs Associated With the Fully-Automatic External Defibrillators
- Stringent Regulations
- Technological Advancements in the Field Of Defibrillators
- Enhancing Investments by Government
- Lack of Awareness and Early Corrective Measures about Sudden Cardiac Arrest
- Adverse Effects Associated With Fully Automated External Defibrillator (AED) and Product Failures
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Philips (Netherlands), HeartSine Technologies (United Kingdom), Laerdal Medical (Norway), Zoll Medical Corporation (United States), Schiller AG (Switzerland), Physio-Control (United States), Defibtech (United States), Nihon Kohden (Japan), Cardiac Science Corporation (United States), A.M.I. Italia Srl (Italy), Mindray (China), Metrax GmbH (Germany), METsis (Turkey), Mediana Co., Ltd. (South Korea) and Instramed (Brazil). Analyst at AMA Research see European Players to retain maximum share of Global Fully-Automatic External Defibrillators market by 2026. Considering Market by Sales Channel, the sub-segment i.e. Online will boost the Fully-Automatic External Defibrillators market.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Fully-Automatic External Defibrillators market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Fully-Automatic External Defibrillators market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Fully-Automatic External Defibrillators, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.